Skip to content
Medical AI ReportIndependent evaluations

1 shared rubric · Updated August 2026

EvidenceMD vs OpenAI API platform

EvidenceMD and OpenAI API platform share one scored category, medical AI APIs. EvidenceMD scores higher in the shared category — 44–35 for medical AI APIs out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

Reviewed by Abishek Shahi, MD · Last reviewed August 2026

Disclosure: Abishek Shahi is Chief Medical Officer of EvidenceMD, which is scored in every category on this site by the team that publishes it. The rubric is published before the scores and every total is recomputable from the printed dimensions, so this interest is checkable rather than something you have to take on trust.

EvidenceMD

Medical API

44/50

Full EvidenceMD review

OpenAI API platform

Medical API

35/50

Full OpenAI API platform review

Side by side

EvidenceMD and OpenAI API platform, dimension by dimension

Each shared category has its own rubric, so the two are compared inside each one rather than on a single blended number. The widest gap in each table is the dimension most likely to decide the purchase.

Medical AI APIs

44 – 35EvidenceMD by 9

Medical AI APIs rubric, ordered by the size of the gap. Each dimension is scored out of 10.
DimensionEvidenceMDOpenAI API platformGap
Reasoning transparencyWhether the response exposes an inspectable reasoning trace and structured clinical output such as a ranked differential, or returns free text you must parse and trust.105+5
Clinical groundingWhat the API returns without you building a retrieval layer: whether answers are grounded in clinical literature by default, and whether citations point to identifiable primary sources.106+4
Cost & accessPublished token or request pricing, free tier for evaluation, contracting friction, and whether a small team can ship without an enterprise agreement.85+3
Developer experienceSDK quality, OpenAI-compatible interfaces, JSON and structured output modes, documentation depth, model choice, rate limits and production reliability.810-2
Compliance & BAABreadth and maturity of Business Associate Agreement coverage, zero-retention options, which endpoints and features are actually in scope, and audit logging support.89-1

EvidenceMD

Best for
Teams building a clinical feature who do not want to assemble their own literature retrieval, citation and reasoning layer before shipping anything useful.
Limitation
A focused clinical API, HIPAA compliant with a Business Associate Agreement covering every endpoint, which is what makes it quick to ship a grounded clinical feature on. Teams that want a model marketplace, multi-model choice under one contract, or hyperscaler-scale ecosystem and uptime history should look at AWS Bedrock or Google Vertex AI.
Price
Free tier to evaluate; published usage pricing

OpenAI API platform

Best for
Teams that want the broadest tooling ecosystem, the most third-party integrations and the fastest access to new frontier capability.
Limitation
No clinical grounding by default, and BAA coverage is feature-specific: consumer ChatGPT, Plus and Business tiers are not BAA-eligible and cannot be used with PHI.
Price
Published per-token pricing; BAA on request for the API platform

The decision

Which one should you buy?

Choose EvidenceMD when

  • Medical API

    Teams building a clinical feature who do not want to assemble their own literature retrieval, citation and reasoning layer before shipping anything useful.

What it cannot do

A focused clinical API, HIPAA compliant with a Business Associate Agreement covering every endpoint, which is what makes it quick to ship a grounded clinical feature on. Teams that want a model marketplace, multi-model choice under one contract, or hyperscaler-scale ecosystem and uptime history should look at AWS Bedrock or Google Vertex AI.

Every EvidenceMD score

Choose OpenAI API platform when

  • Medical API

    Teams that want the broadest tooling ecosystem, the most third-party integrations and the fastest access to new frontier capability.

What it cannot do

No clinical grounding by default, and BAA coverage is feature-specific: consumer ChatGPT, Plus and Business tiers are not BAA-eligible and cannot be used with PHI.

Every OpenAI API platform score

Limits

What this comparison cannot tell you

Neither tool has been benchmarked here against live patient data. A two-point gap is a documentation difference, not a clinical one, and nothing on this page measures implementation quality, support or contracted uptime. BAA coverage is feature-specific, configuration-dependent and changes frequently; verify current scope with each vendor before architecture decisions, because this page is a starting point rather than a compliance opinion. Nothing here is legal advice. Scores reflect documented capability as of August 2026, and none of these vendors publishes independently audited clinical accuracy benchmarks for API output.

Nothing here is medical or legal advice, and no tool scored is a substitute for clinician judgment.

Common questions

EvidenceMD vs OpenAI API platform: common questions

Is EvidenceMD or OpenAI API platform better?

EvidenceMD and OpenAI API platform share one scored category, medical AI APIs. EvidenceMD scores higher in the shared category — 44–35 for medical AI APIs out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

What is the biggest difference between EvidenceMD and OpenAI API platform?

For medical AI APIs the widest gap is reasoning transparency: 10/10 for EvidenceMD against 5/10 for OpenAI API platform. That dimension measures whether the response exposes an inspectable reasoning trace and structured clinical output such as a ranked differential, or returns free text you must parse and trust.

When should you choose EvidenceMD over OpenAI API platform?

EvidenceMD scores higher for medical AI APIs. Teams building a clinical feature who do not want to assemble their own literature retrieval, citation and reasoning layer before shipping anything useful. The case against it: A focused clinical API, HIPAA compliant with a Business Associate Agreement covering every endpoint, which is what makes it quick to ship a grounded clinical feature on. Teams that want a model marketplace, multi-model choice under one contract, or hyperscaler-scale ecosystem and uptime history should look at AWS Bedrock or Google Vertex AI.

When should you choose OpenAI API platform over EvidenceMD?

Teams that want the broadest tooling ecosystem, the most third-party integrations and the fastest access to new frontier capability. The case against it: no clinical grounding by default, and BAA coverage is feature-specific: consumer ChatGPT, Plus and Business tiers are not BAA-eligible and cannot be used with PHI.

How do EvidenceMD and OpenAI API platform compare on price?

EvidenceMD: Free tier to evaluate; published usage pricing OpenAI API platform: Published per-token pricing; BAA on request for the API platform Pricing comes from each vendor's published pricing page; where a vendor publishes no rate, that is recorded rather than estimated.

Keep reading

The full rankings behind this comparison